Bio-Techne
TECH
511 hedge funds and large institutions have $16.4B invested in Bio-Techne in 2021 Q2 according to their latest regulatory filings, with 84 funds opening new positions, 160 increasing their positions, 173 reducing their positions, and 40 closing their positions.
110% more first-time investments, than exits
New positions opened: 84 | Existing positions closed: 40
18% more capital invested
Capital invested by funds: $13.9B → $16.4B (+$2.5B)
9% more funds holding
Funds holding: 470 → 511 (+41)
0.96% less ownership
Funds ownership: 377.47% → 376.51% (-0.96%)
8% less repeat investments, than reductions
Existing positions increased: 160 | Existing positions reduced: 173
19% less funds holding in top 10
Funds holding in top 10: 16 → 13 (-3)
54% less call options, than puts
Call options by funds: $53.9M | Put options by funds: $118M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$275M |
| 2 |
State Street
Boston,
Massachusetts
|
+$135M |
| 3 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
+$134M |
| 4 |
Thrivent Financial for Lutherans
Minneapolis,
Minnesota
|
+$69.4M |
| 5 |
AIM
Artemis Investment Management
Edinburgh,
United Kingdom
|
+$67.7M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BCM
Brown Capital Management
Baltimore,
Maryland
|
-$108M |
| 2 |
Invesco
Atlanta,
Georgia
|
-$77.3M |
| 3 |
Marshall Wace
London,
United Kingdom
|
-$73.9M |
| 4 |
Millennium Management
New York
|
-$72.9M |
| 5 |
Select Equity Group
New York
|
-$71.2M |
TECH Hedge Fund Activity: Q2 2021 in Review
511 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Bio-Techne (TECH) for Q2 2021, worth a combined $16.4B — up 18% from $13.9B a quarter earlier.
Buyers outnumbered sellers: 84 funds opened new TECH positions and 40 closed out — a net gain of 44 holders — while 160 added to existing stakes and 173 trimmed.
The largest buyer was BlackRock, adding an estimated $275M. The largest seller was Brown Capital Management, cutting an estimated $108M.
- 511 institutional investors held Bio-Techne (TECH) as of Q2 2021, up from 470 in Q1 2021.
- Funds reported $16.4B of Bio-Techne stock for Q2 2021, up 18% quarter-over-quarter.
- 84 funds opened new Bio-Techne positions in Q2 2021 and 40 closed out, a net change of +44 holders.
- The largest Bio-Techne buyer in Q2 2021 was BlackRock, an estimated $275M added.
- The largest Bio-Techne seller in Q2 2021 was Brown Capital Management, an estimated $108M sold.
Based on aggregated 13F filings for Q2 2021.